[HTML][HTML] Clinical practice guidelines for diagnosis and management of cough—Chinese Thoracic Society (CTS) Asthma Consortium

K Lai, H Shen, X Zhou, Z Qiu, S Cai… - Journal of Thoracic …, 2018 - ncbi.nlm.nih.gov
Cough is the most common symptom in respiratory specialist clinics of tertiary hospitals and
outpatient clinics of primary health care facilities. In China, patients with chronic cough …

Palliative endobronchial brachytherapy for non‐small cell lung cancer

L Reveiz, JR Rueda… - Cochrane Database of …, 2012 - cochranelibrary.com
Background This is an updated version of the original review published in Issue 2, 2008 of
The Cochrane Library. Non‐small cell lung cancers (NSCLC) constitute about 80% of all …

Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer

Y Li, X Cui, Y Li, T Zhang, S Li - Cancer Management and …, 2018 - Taylor & Francis
Background Non-small-cell lung cancer (NSCLC) represents the most frequent subtype of
lung cancer. MicroRNAs (miRNAs) have attracted a lot of attention with regard to their …

Interventions for cough in cancer

A Molassiotis, C Bailey, A Caress… - Cochrane Database of …, 2015 - cochranelibrary.com
Background This is an updated version of the original Cochrane review first published in
Issue 9, 2010 on “Interventions for cough in cancer”. Cough is a common symptom in …

A novel tracheobronchial stent loaded with 125I seeds in patients with malignant airway obstruction compared to a conventional stent: a prospective randomized …

Y Wang, J Lu, JH Guo, GY Zhu, HD Zhu, L Chen… - …, 2018 - thelancet.com
Background To evaluate the safety and efficacy of a novel radioactive bare metal stent
(RBMS) compared with a conventional bare metal stent (CBMS) in patients with inoperable …

The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non–small-cell lung cancer: A systematic review

YC Ung, E Yu, C Falkson, AE Haynes, D Stys-Norman… - Brachytherapy, 2006 - Elsevier
PURPOSE: This review addresses the role of high-dose-rate endobronchial brachytherapy
(HDREB) for symptom palliation in patients with non–small-cell lung cancer. METHODS …

[图书][B] A guide to symptom relief in palliative care

C Regnard, M Dean - 2022 - taylorfrancis.com
This established and well-regarded Guide describes the management of patients with
advanced disease. Its foundation is a clinical decision-making approach in which the …

[HTML][HTML] Overview of malignant central airway obstruction

RE Powers, AJ Schwalk - Mediastinum, 2023 - ncbi.nlm.nih.gov
Malignant central airway obstruction (MCAO) impacts many patients with advanced primary
lung cancers and metastatic disease to the thorax and may cause substantial symptoms and …

Malignant central airway obstruction: What's new?

BD Shaller, D Filsoof, JM Pineda… - … in Respiratory and …, 2022 - thieme-connect.com
Malignant central airway obstruction (MCAO) is a debilitating and life-limiting complication
that occurs in an unfortunately large number of individuals with advanced intrathoracic …

Interventional pulmonology: a brave new world

HS Kalsi, R Thakrar, AF Gosling… - Thoracic surgery …, 2020 - thoracic.theclinics.com
The past decade has seen somewhat of a shift away from diagnostic thoracic surgery due
largely to a rapid development in technologies in interventional pulmonology (IP) …